Clinical trial

Short Course Terlipressin for Control of Acute Variceal Bleeding

NCT00369694

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Terlipressin Normalized identity: terlipressinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Terlipressin & then Dummy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Short Course Terlipressin for Control of Acute Variceal Bleeding

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-08-01

PhasePHASE4

Conditions

Hemorrhageunresolved

Esophageal Varicesverified · MONDO: esophageal varices

Portal Hypertensionverified · MONDO: portal hypertension

Interventions

TerlipressinDRUG · verified · RxNorm: terlipressin

Terlipressin & then DummyDRUG

Sponsors & collaborators

Aga Khan Universitylead sponsor

Ferozsons Laboratories Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00369694 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.